Hari Menon
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- James W. WelshMaría Angélica CortezHampartsoum B. BarsoumianRishab RamapriyanVivek VermaDawei ChenAhmed YounesJoe Y. Chang
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Lung Cancer Treatments and Mutations (8 papers)Lung Cancer Diagnosis and Treatment (6 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesIndiaChina
In The Last Decade
Hari Menon
44 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 73
- Oncology 661
- Pulmonary and Respiratory Medicine 398
- Immunology 330
- Molecular Biology 321
- Cancer Research 227
Countries citing papers authored by Hari Menon
This map shows the geographic impact of Hari Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hari Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hari Menon more than expected).
Fields of papers citing papers by Hari Menon
This network shows the impact of papers produced by Hari Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hari Menon. The network helps show where Hari Menon may publish in the future.
Co-authorship network of co-authors of Hari Menon
This figure shows the co-authorship network connecting the top 25 collaborators of Hari Menon. A scholar is included among the top collaborators of Hari Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hari Menon. Hari Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 63 | |
| 4 | 7 | |
| 5 | 29 | |
| 6 | 20 | |
| 7 | 54 | |
| 8 | 26 | |
| 9 | 57 | |
| 10 | 40 | |
| 11 | 113 | |
| 12 | 20 | |
| 13 | 9 | |
| 14 | 118 | |
| 15 | 12 | |
| 16 | A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 2 STUDY OF GANITUMAB OR RILOTUMUMAB WITH PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (SCLC) | 4 |
| 17 | 7 | |
| 18 | 6 | |
| 19 | 8 | |
| 20 | 4 |
About Hari Menon
Hari Menon is a scholar working on Oncology, Hematology and Immunology, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (661 citations), Immunology (330 citations) and Cancer Research (227 citations). Hari Menon has collaborated with scholars based in United States, India and China. Frequent co-authors include James W. Welsh, María Angélica Cortez, Hampartsoum B. Barsoumian, Rishab Ramapriyan, Vivek Verma, Dawei Chen, Ahmed Younes, Joe Y. Chang, Mehmet Altan and Mauricio S. Caetano. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.